Sonnet Begin Period Cash Flow vs Dividends Paid Analysis

SONN Stock  USD 1.91  0.07  3.54%   
Sonnet Biotherapeutics financial indicator trend analysis is much more than just breaking down Sonnet Biotherapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sonnet Biotherapeutics is a good investment. Please check the relationship between Sonnet Biotherapeutics Begin Period Cash Flow and its Dividends Paid accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Begin Period Cash Flow vs Dividends Paid

Begin Period Cash Flow vs Dividends Paid Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sonnet Biotherapeutics Begin Period Cash Flow account and Dividends Paid. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Sonnet Biotherapeutics' Begin Period Cash Flow and Dividends Paid is 0.15. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Dividends Paid in the same time period over historical financial statements of Sonnet Biotherapeutics Holdings, assuming nothing else is changed. The correlation between historical values of Sonnet Biotherapeutics' Begin Period Cash Flow and Dividends Paid is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Sonnet Biotherapeutics Holdings are associated (or correlated) with its Dividends Paid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Dividends Paid has no effect on the direction of Begin Period Cash Flow i.e., Sonnet Biotherapeutics' Begin Period Cash Flow and Dividends Paid go up and down completely randomly.

Correlation Coefficient

0.15
Relationship DirectionPositive 
Relationship StrengthInsignificant

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.
Most indicators from Sonnet Biotherapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sonnet Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
As of the 12th of December 2024, Tax Provision is likely to grow to about 69.7 K, while Selling General Administrative is likely to drop about 2.4 M.

Sonnet Biotherapeutics fundamental ratios Correlations

0.810.870.820.70.190.280.450.71-0.10.240.560.190.880.160.73-0.37-0.120.13-0.090.13-0.17-0.280.580.35-0.62
0.810.890.390.810.40.720.180.84-0.070.020.790.090.95-0.320.92-0.2-0.09-0.34-0.12-0.34-0.43-0.240.50.17-0.5
0.870.890.520.730.260.50.360.74-0.010.410.620.410.96-0.050.86-0.28-0.38-0.1-0.26-0.1-0.04-0.40.720.32-0.66
0.820.390.520.39-0.04-0.170.390.36-0.150.260.140.140.470.510.43-0.370.050.49-0.070.49-0.06-0.110.270.39-0.39
0.70.810.730.390.40.660.310.98-0.40.070.83-0.140.77-0.380.730.230.17-0.390.02-0.39-0.46-0.290.530.42-0.58
0.190.40.26-0.040.40.19-0.240.420.370.010.720.10.37-0.050.30.41-0.090.00.280.0-0.3-0.20.32-0.09-0.51
0.280.720.5-0.170.660.190.00.69-0.24-0.290.64-0.210.6-0.880.67-0.030.13-0.89-0.01-0.89-0.55-0.020.130.07-0.12
0.450.180.360.390.31-0.240.00.3-0.390.270.090.040.320.140.08-0.17-0.070.09-0.060.090.25-0.40.350.3-0.23
0.710.840.740.360.980.420.690.3-0.4-0.010.88-0.150.81-0.40.730.220.16-0.41-0.06-0.41-0.49-0.30.570.31-0.62
-0.1-0.07-0.01-0.15-0.40.37-0.24-0.39-0.40.27-0.080.580.010.3-0.1-0.28-0.610.30.230.30.30.290.08-0.20.0
0.240.020.410.260.070.01-0.290.27-0.010.27-0.120.750.20.480.12-0.06-0.690.42-0.20.420.56-0.410.620.52-0.41
0.560.790.620.140.830.720.640.090.88-0.08-0.12-0.10.77-0.390.590.280.04-0.370.13-0.37-0.48-0.270.550.04-0.63
0.190.090.410.14-0.140.1-0.210.04-0.150.580.75-0.10.250.440.2-0.29-0.950.37-0.20.370.62-0.320.43-0.03-0.21
0.880.950.960.470.770.370.60.320.810.010.20.770.25-0.170.83-0.28-0.27-0.2-0.09-0.2-0.21-0.350.670.22-0.65
0.16-0.32-0.050.51-0.38-0.05-0.880.14-0.40.30.48-0.390.44-0.17-0.28-0.16-0.320.99-0.090.990.54-0.160.170.03-0.17
0.730.920.860.430.730.30.670.080.73-0.10.120.590.20.83-0.28-0.22-0.11-0.3-0.3-0.3-0.38-0.20.360.22-0.41
-0.37-0.2-0.28-0.370.230.41-0.03-0.170.22-0.28-0.060.28-0.29-0.28-0.16-0.220.29-0.12-0.01-0.12-0.16-0.090.13-0.02-0.17
-0.12-0.09-0.380.050.17-0.090.13-0.070.16-0.61-0.690.04-0.95-0.27-0.32-0.110.29-0.250.16-0.25-0.640.32-0.490.120.18
0.13-0.34-0.10.49-0.390.0-0.890.09-0.410.30.42-0.370.37-0.20.99-0.3-0.12-0.25-0.071.00.48-0.120.130.01-0.16
-0.09-0.12-0.26-0.070.020.28-0.01-0.06-0.060.23-0.20.13-0.2-0.09-0.09-0.3-0.010.16-0.07-0.07-0.10.11-0.260.10.16
0.13-0.34-0.10.49-0.390.0-0.890.09-0.410.30.42-0.370.37-0.20.99-0.3-0.12-0.251.0-0.070.48-0.120.130.01-0.16
-0.17-0.43-0.04-0.06-0.46-0.3-0.550.25-0.490.30.56-0.480.62-0.210.54-0.38-0.16-0.640.48-0.10.48-0.190.18-0.09-0.05
-0.28-0.24-0.4-0.11-0.29-0.2-0.02-0.4-0.30.29-0.41-0.27-0.32-0.35-0.16-0.2-0.090.32-0.120.11-0.12-0.19-0.49-0.130.45
0.580.50.720.270.530.320.130.350.570.080.620.550.430.670.170.360.13-0.490.13-0.260.130.18-0.490.35-0.81
0.350.170.320.390.42-0.090.070.30.31-0.20.520.04-0.030.220.030.22-0.020.120.010.10.01-0.09-0.130.35-0.35
-0.62-0.5-0.66-0.39-0.58-0.51-0.12-0.23-0.620.0-0.41-0.63-0.21-0.65-0.17-0.41-0.170.18-0.160.16-0.16-0.050.45-0.81-0.35
Click cells to compare fundamentals

Sonnet Biotherapeutics Account Relationship Matchups

Sonnet Biotherapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets29.8M8.0M29.0M5.8M5.4M28.3M
Short Long Term Debt Total10.3M353.3K125.9K256.0K203.9K9.8M
Total Current Liabilities13.0M4.7M6.7M8.2M5.5M12.4M
Total Stockholder Equity7.4M3.0M22.3M(2.5M)(226.0K)8.9M
Property Plant And Equipment Net9.8M273.8K182.3K302.8K227.1K10.2M
Net Debt9.8M(7.0M)(27.5M)(2.8M)(2.1M)9.3M
Accounts Payable2.4M2.1M3.8M4.8M2.2M2.3M
Non Current Assets Total28.4M356.8K182.3K416.1K691.2K27.0M
Liabilities And Stockholders Equity29.8M8.0M29.0M5.8M5.4M28.3M
Non Current Liabilities Total8.5M250.0K30.6K203.9K130.9K8.1M
Other Stockholder Equity64.1M39.7M83.9M88.9M110.0M60.9M
Total Liab21.5M5.0M6.7M8.4M5.7M20.5M
Total Current Assets1.3M7.6M28.8M5.4M4.7M1.3M
Short Term Debt6.7M103.2K95.3K52.1K73.0K6.3M
Common Stock373.01.5K6.0K554.0175.0354.35
Retained Earnings(57.1M)(36.7M)(61.7M)(91.4M)(110.2M)(60.0M)
Cash524.1K7.3M27.6M3.1M2.3M497.9K
Non Currrent Assets Other2.9M83.0K(182.3K)113.3K464.2K2.7M
Cash And Short Term Investments524.1K7.3M27.6M3.1M2.3M497.9K
Other Current Assets159.2K575.5K2.4M4.0M1.7M151.2K
Other Current Liab2.8M2.1M2.3M3.2M3.2M2.7M
Common Stock Shares Outstanding439.5830.6K79.7K197.5K1.0M417.6
Property Plant And Equipment Gross9.8M273.8K182.3K302.8K227.1K5.3M
Net Tangible Assets7.4M3.0M22.3M(2.5M)8.5M9.0M

Pair Trading with Sonnet Biotherapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sonnet Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Sonnet Stock

  0.86VALN Valneva SE ADRPairCorr
  0.82ERNA Eterna TherapeuticsPairCorr

Moving against Sonnet Stock

  0.93BMY Bristol Myers SquibbPairCorr
  0.81ESPR Esperion TherapeuticsPairCorr
  0.8GILD Gilead SciencesPairCorr
  0.56DYAI Dyadic InternationalPairCorr
  0.43DNA Ginkgo Bioworks HoldingsPairCorr
The ability to find closely correlated positions to Sonnet Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sonnet Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sonnet Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sonnet Biotherapeutics Holdings to buy it.
The correlation of Sonnet Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sonnet Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sonnet Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sonnet Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.96)
Revenue Per Share
0.019
Quarterly Revenue Growth
(0.50)
Return On Assets
(0.97)
Return On Equity
(2.65)
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.